⌕
Ceribell · CBLL · Nasdaq
Tenet 47 · Mixed
Compare
$27.13−0.99%At closeTenet 47 · Mixed
$27.13−0.27 (−0.99%)
At close: Oct 23, 2026, 4:00 PM ET· Nasdaq · USD

Ceribell (CBLL) Stock

Ceribell (CBLL) closed at $27.13 on Oct 23, 2026; its Tenet Score is 47 of 100 against 400 Healthcare peers.

Sources Company filings, market prices and computed by Tenet Filings, prices and TenetScore as of How we compute thisNot investment advice

Key stats

Previous close
$27.13
Oct 23, 2026
Market cap
$1.0B
share price × the latest quarter's diluted weighted-average share count (vendor)
Dividend yield
0.00%
reinvests all
52-week range
10.85 – 28.11
low → high
Tenet Score
47/100
Mixed · 400 Healthcare peers

Industry: Surgical, Medical, and Dental Instruments and Supplies · see every company filed here →

Ceribell Inc. scores 47/100. Mixed. Strongest on financial health, value is the soft spot versus 400 Healthcare peers. Insufficient inputs: Tenet 47 is built from 3 of 4 pillars, from 55% of its inputs. Growth is left out because no growth rate could be measured.

Tenet Score · vs sector

n=400
47/ 100
Mixed
Fundamental composite — rates the business, not the timing.
Each metric's standing vs the company's own record is shown on the Statistics tab.
Value
24
Quality
40
Health
75
Growth
—

Factor grades

Grid rings: 25 · 50 · 75 · 100 percentile
Growth omitted — no data yet.
ValueFQualityDHealthBGrowth—MomentumA
A grade is a label over the shown score. Value/Quality/Health/Growth are sector percentiles; Momentum ranks 12−1 return across the equity universe — a lens, never folded into the Tenet Score.
Show the math →

Price

Loading chart…
P/E
—
net income is at or below zero, so P/E is not meaningful
P/B
8.0×
cap ÷ Jun 30, 2026 book value, Oct 23, 2026 close
P/S
11.6×
price to fiscal 2025 sales
ROE
−44%
TTM through Jun 30, 2026
Operating margin
−65.6%
fiscal 2025, before interest and tax
Net margin
−64.7%
TTM through Jun 30, 2026
Current ratio
9.18
Jun 30, 2026 balance sheet
Net debt / EBITDA
—
negative EBITDA denominator
EPS CAGR 5y
—
needs five years of positive earnings

The whole report, at a glance · every card is a live peek, click any to open the section

Tenets
3 / 17
  • ✕ Buffett Quality
  • ✕ Piotroski F-Score
  • ✕ Graham Defensive
  • ~ Drawdown Context
  • ✓ Reversal Evidence
  • ✕ Quality Floor
+11 more →
Financials
Revenue, margins and the five-year statements.
Analyst Forecasts
−18.5%
forward EPS growth (consensus) · 6 analysts
Earnings
Report dates and the beat-versus-miss record.
Statistics
ROIC−47%
Gross margin89%
Debt / equity0.16
Technical Analysis
Uptrend short-term signal
vs 50-day+10.2%
vs 200-day+31.2%
RSI (14)59
News & Insights
Recent headlines with their publishers and dates.
Dividends
0.00% yield

No dividend. Cash stays in the business.

Ownership
74% institutional

13F flows & insider trades land here.

About Ceribell Inc.

We are a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. We have developed the Ceribell System, a novel, point-of-care electroencephalography (“EEG”) platform…

Composite computed Oct 26, 2026 · peer basis: Healthcare (n=400) · every glimpse links to its full section with sources · not investment advice.

ETF exposure

held by 39 US ETFs · top wrappers by weightSee all ETFs holding CBLL →

Similar-sized companies in Surgical, Medical, and Dental Instruments and Supplies

The 5 companies in this industry closest in market cap, as of Oct 23, 2026.

CompanyTenet ScoreMarket cap
Medline IncMDLN48$29.3B
Solventum CorpSOLV54$14.5B
MiniMed Group IncMMED44$5.2B
Heartflow IncHTFL39$4.9B
Kestra Medical Technologies Ltd.KMTS42$1.7B

Common questions

What sector and industry is Ceribell in?

Ceribell is in the Healthcare sector and the Surgical, Medical, and Dental Instruments and Supplies industry.

What is Ceribell's Tenet Score?

Ceribell's Tenet Score is 47 out of 100, ranked against 400 Healthcare peers as of Oct 26, 2026.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.